Endo-ERN

Iperplasia surrenalica Congenita nelle diverse età

An update on primordial dwarfism conditions

Diagnosis and management of TSH resistance

Genotype phenotype correlations in CAH

EuRREB Rare disease research and the value of registries

Cushing's disease and Cushing's syndrome

Congenital combined pituitary hormone deficiency in Europe

REMEDI4ALL / drug repurposing and clinical trial readiness by Anton Ussi

Patient-Reported Outcomes and considerations before including them in a clinical trial.

Framework for Patient Engagement in Clinical Trials

c4c expert advice, patient and public involvement, data standards

Essential requirements before thinking about a clinical trial

Designing and conducting clinical trials in rare diseases – industry expectation for partners

Definition of orphan drug by the EMA

c4c trials, education and training

سجلات ERN والتعاون الأوروبي في مجال الأمراض النادرة

ERN-registers en Europese samenwerking op het gebied van zeldzame ziekten

ERN-Register und Kooperation zu seltenen Erkrankungen in Europa

Alessia Dolci CPMS 2.0 Testimonial

Registres ERN et collaboration sur les maladies rares en Europe

ERN Registries and Rare Disease Collaboration Across Europe

'Novel monitoring tools to detect chronic over or under treatment in children with CAH

Fibrous Dysplasia with emphasis on hypophosphataemia 2 (reupload with new data)

Endo-ERN Information Webinar CPMS 2.0

Long term outcomes in CAIS

Care of adult patients with Klinefelter syndrome

Update SGA, GH treatment beyond childhood

Adrenoleukodystrophy Presentation of two siblings